Hims & Hers Health Inc (NYSE: HIMS) kicked off on Monday, up 5.22% from the previous trading day, before settling in for the closing price of $42.55. Over the past 52 weeks, HIMS has traded in a range of $9.14-$46.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Consumer Defensive Sector giant was 60.52%. While this was happening, its average annual earnings per share was recorded 592.48%. With a float of $176.71 million, this company’s outstanding shares have now reached $209.44 million.
Let’s determine the extent of company efficiency that accounts for 1046 employees. In terms of profitability, gross margin is 77.58%, operating margin of 2.84%, and the pretax margin is 4.16%.
Hims & Hers Health Inc (HIMS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Household & Personal Products Industry. The insider ownership of Hims & Hers Health Inc is 19.12%, while institutional ownership is 64.92%. The most recent insider transaction that took place on Feb 10 ’25, was worth 314,170. Before that another transaction happened on Feb 04 ’25, when Company’s Chief Financial Officer sold 11,581 for $38.92, making the entire transaction worth $450,730. This insider now owns 112,933 shares in total.
Hims & Hers Health Inc (HIMS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 592.48% per share during the next fiscal year.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Take a look at Hims & Hers Health Inc’s (HIMS) current performance indicators. Last quarter, stock had a quick ratio of 1.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.88. Likewise, its price to free cash flow for the trailing twelve months is 65.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.43, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.52 in one year’s time.
Technical Analysis of Hims & Hers Health Inc (HIMS)
Looking closely at Hims & Hers Health Inc (NYSE: HIMS), its last 5-days average volume was 16.93 million, which is a jump from its year-to-date volume of 12.02 million. As of the previous 9 days, the stock’s Stochastic %D was 81.29%. Additionally, its Average True Range was 2.97.
During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 95.90%, which indicates a significant increase from 92.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.57% in the past 14 days, which was lower than the 102.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.88, while its 200-day Moving Average is $21.88. However, in the short run, Hims & Hers Health Inc’s stock first resistance to watch stands at $46.20. Second resistance stands at $47.62. The third major resistance level sits at $50.07. If the price goes on to break the first support level at $42.32, it is likely to go to the next support level at $39.88. Should the price break the second support level, the third support level stands at $38.45.
Hims & Hers Health Inc (NYSE: HIMS) Key Stats
The company with the Market Capitalisation of 9.78 billion has total of 218,479K Shares Outstanding. Its annual sales at the moment are 872,000 K in contrast with the sum of -23,550 K annual income. Company’s last quarter sales were recorded 401,560 K and last quarter income was 75,590 K.
